Cutaneous tumors as the initial presentation of non-T, non-B, nonmyeloid CD4+ CD56+ hematolymphoid malignancy in an adolescent boy

Pediatric Dermatology

Volumn 22, Issue 1, 2005, Pages 19-22

  Fass, Jonathan ^a   Tichy, Elizabeth H ^a   Kraus, Eric W ^a   Herrick, Jennifer L ^a   Ehsan, Aamir ^a   Peterson, Joe ^a   Grimwood, Ronald E ^a  

^a University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; TIOGUANINE;

ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; DISEASE COURSE; FLOW CYTOMETRY; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MONONUCLEAR CELL; NON T NON B NONMYELOID HEMATOLYMPHOID MALIGNANCY; PRIORITY JOURNAL; SKIN BIOPSY; SKIN TUMOR; TUMOR GROWTH;

ADOLESCENT; ANTIGENS, CD4; ANTIGENS, CD56; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; SKIN NEOPLASMS;

EID: 12944314892     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2005.22104.x     Document Type: Article

References (7)

1. + cutaneous neoplasm, A distinct hematol entity? Am J Surg Pathol 1999;23(2):137-146.
2. + lymphoma. Arch Dermatol 1996;132:550-553.
3. + hematodermic/hematolymphoid malignancy. J Am Acad Derm 2001;44(2):231-238.
4. + myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood 1997;90(6): 2417-2428.
5. Chan J, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89(12):4501-4513.
6. Chan JKC, Jaffe ES, Ralfkiaer E. Blastic NK-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics: tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
7. Gould JW, Eppes RB, Gilliam AC, et al. Solitary primary cutaneous CD30+ large cell lymphoma of natural killer cell phenotype bearing the t(2;5) (p23;q35) translocation and presenting in a child. Amer J Derm 2000;22(5):422-428.